Clinical trial
Treatment of Acute Ischemic StroKe With Intravenous UroKinase Real-world Research: a Multicenter, Prospective Study (TASK-UK)
NCT06194968 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Zhengzhou University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Acute Ischemic StroKe With Intravenous UroKinase Real-world Research: a Multicenter, Prospective Study (TASK-UK)
- Lead sponsor
- The First Affiliated Hospital of Zhengzhou University
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- December 30, 2023
- Completion date
- December 1, 2026
- Enrollment
- 1,800 (estimated)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.
acute ischemic stroke